Pakistan introduces digital drug tracking framework to to combat counterfeit medicines

In a significant move to eliminate counterfeit medicines across the country, the Federal Cabinet has formally approved the implementation of a nationwide Track and Trace System for pharmaceuticals.

Federal Minister for Health, Mustafa Kamal, stated that the necessary amendments to the Drug Labelling and Packing Rules 1978 have been approved. He described the decision as a major and historic step towards eradicating counterfeit medicines in Pakistan.

The Minister noted that, for the first time, every medicine will be capable of being digitally tracked and verified. Under the new system, counterfeit, substandard and falsified medicines can be identified and removed more effectively.

The initiative will also enable consumers to access verified information regarding a medicine’s expiry date and price with ease.

He further explained that the Drug Regulatory Authority of Pakistan will oversee the nationwide implementation of this advanced system.

Under the revised regulations, all pharmaceutical manufacturers and importers will be required to print a standardised two-dimensional barcode and serialisation data on every medicine package.

The measure has been introduced to enhance the security, transparency and quality of the pharmaceutical supply chain.

According to the Health Minister, Pakistan’s medicines regulatory framework is being modernised in line with international standards. He emphasised that the Track and Trace System will serve as a strong and effective safeguard against counterfeit medicines, while positioning Pakistan as a leading adopter of modern pharmaceutical technology within the region.

The new framework will also replace traditional monitoring practices with a more advanced digital oversight system.